Brian Goff, Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 24,132 shares at $22.99 ($555K) on 2024-01-09, disclosed to the SEC on 2024-01-09.
Scheduled sale ($555k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.99 | 12,066 | $277K | 50.0% |
| 2 | $22.99 | 12,066 | $277K | 50.0% |
| Total | $22.99 avg | 24,132 | $555K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $507K | — | Filing → |
| AGIO | SELL | 2025-08-12 | $813K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $1.3M | — | Filing → |